Literature DB >> 24752353

Some findings of FADD knockdown in inhibition of HIV-1 replication in Jurkat cells and PBMCs.

Xue Wang1, Jiying Tan, Jiangqin Zhao, Viswannath Ragupathy, Mohan Haleyurgirisetty, Indira Hewlett.   

Abstract

Fas-associated protein with death domain (FADD) is a key adaptor molecule transmitting the death signal mediated by death receptors, and it is also required for T cell proliferation. A recent study indicated that FADD is able to affect HIV-1 production, but the mechanism is not known. Using the susceptible Jurkat cell line and peripheral blood mononuclear cells, we studied the effects of FADD on HIV-1 production. TaqMan RT-PCR was used to quantify HIV-1 viral RNA copies, and Western blot analysis was used to detect protein expression. FADD knockdown decreased HIV-1 replication and inactivated caspase-3 activity in the cells and blocked CD4 translocation to the lipid rafts of the plasma membrane. Reduced expression of FADD suppressed TCR signaling through downregulation of TCR, CD3, and Zap-70 in response to HIV-1 infection and blocked the trafficking of TCR, CD3, CD28, and Zap-70 to lipid rafts, leading to reduced activation of NF-κB and NFAT, which are required for HIV-1 replication. FADD knockdown diminished caspase-8 migration to lipid rafts and its expression in response to HIV-1 infection. These results indicate that FADD, as a host pro-apoptotic protein, plays important roles in regulating HIV-1 replication and production in several ways, and apoptotic pathway inhibition is able to decrease HIV-1 replication and production.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24752353     DOI: 10.1007/s11010-014-2058-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  36 in total

Review 1.  Hostile takeovers: viral appropriation of the NF-kappaB pathway.

Authors:  J Hiscott; H Kwon; P Génin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

2.  Fine-tuning of proximal TCR signaling by ZAP-70 tyrosine residues in Jurkat cells.

Authors:  M Szabo; T Czompoly; K Kvell; G Talaber; D Bartis; P Nemeth; T Berki; F Boldizsar
Journal:  Int Immunol       Date:  2011-12-29       Impact factor: 4.823

Review 3.  Posttranslational modifications of NEMO and its partners in NF-kappaB signaling.

Authors:  Hélène Sebban; Shoji Yamaoka; Gilles Courtois
Journal:  Trends Cell Biol       Date:  2006-09-20       Impact factor: 20.808

4.  A role for FADD in T cell activation and development.

Authors:  C M Walsh; B G Wen; A M Chinnaiyan; K O'Rourke; V M Dixit; S M Hedrick
Journal:  Immunity       Date:  1998-04       Impact factor: 31.745

Review 5.  Viral entry, lipid rafts and caveosomes.

Authors:  Vilja M Pietiäinen; Varpu Marjomäki; Jyrki Heino; Timo Hyypiä
Journal:  Ann Med       Date:  2005       Impact factor: 4.709

Review 6.  HIV entry and its inhibition.

Authors:  D C Chan; P S Kim
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

7.  Mechanism of host cell MAPK/ERK-2 incorporation into lentivirus particles: characterization of the interaction between MAPK/ERK-2 and proline-rich-domain containing capsid region of structural protein Gag.

Authors:  Pankaj Gupta; Prabhat K Singhal; Palakurthy Rajendrakumar; Yogendra Padwad; Ashish V Tendulkar; V S Kalyanaraman; Reinhold E Schmidt; A Srinivasan; S Mahalingam
Journal:  J Mol Biol       Date:  2011-07-22       Impact factor: 5.469

Review 8.  HIV/AIDS Review.

Authors:  Joseph Anthony Moss
Journal:  Radiol Technol       Date:  2013 Jan-Feb

Review 9.  The role of cellular factors in promoting HIV budding.

Authors:  Eric R Weiss; Heinrich Göttlinger
Journal:  J Mol Biol       Date:  2011-07-22       Impact factor: 5.469

10.  Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis.

Authors:  F Silvestris; P Cafforio; M A Frassanito; M Tucci; A Romito; S Nagata; F Dammacco
Journal:  AIDS       Date:  1996-02       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.